The global Dental Membrane And Bone Graft Substitute Market is estimated to be valued at US$ 1,045.3 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Dental membrane and bone graft substitutes are used for guided bone and tissue regeneration procedures in dental procedures like implants, extractions and periodontal surgeries. Membranes act as barriers and help prevent the invasion of unwanted soft tissues into the regenerating bone or tissue. They provide space for new bone to grow into a defect site.
Market key trends:
Biocompatibility, space making, and osteoconductivity are the key functions of bone graft substitutes. Synthetic bone graft substitutes are increasingly being preferred over autografts as they overcome the limitations of donor site morbidity and availability of tissue. They help accelerate the bone formation process through osteoconduction and are increasingly being used for alveolar ridge augmentation, sinus lifts and socket preservation. Demand for tissue regenerative procedures owing to rising dental implants is fueling growth of the market.
Segment Analysis
The global dental membrane and bone graft substitute market is segmented based on membrane type, bone graft type, product, application, end user, and geography. Under membrane type, resorbable membrane is the dominating segment as it is increasingly preferred over non-resorbable membrane. Resorbable membrane guides bone regeneration while being absorbed in the body over time, eliminating the need for another surgery for its removal.
Key Takeaways
The global dental membrane and bone graft substitute market is expected to witness high growth, exhibiting CAGR of 9.4% over the forecast period, due to increasing incidence of dental diseases and rising demand for dental procedures.
Regional analysis
North America dominated the global market in 2023 and is expected to maintain its dominance over the forecast period. This is attributed to factors such as rising healthcare expenditure, increasing awareness regarding oral health, and presence of key players in the region. Asia Pacific is expected to exhibit the fastest growth rate owing to growing medical tourism industry and improving healthcare infrastructure in emerging economies.
Key players analysis
Key players operating in the dental membrane and bone graft substitute market are Zimmer Biomet, Geistlich Pharma North America Inc., ACE Surgical Supply Company, Inc., BioHorizons, LifeNet Health, RTI Surgical, Institut Straumann AG, Dentsply Sirona Inc., Citagenix, Inc., Orthogen AG, DentiumUSA, KaVo Dental, Danaher, BONESUPPORT AB, Cerapedics, Inc., Molecular Matrix, Inc., Medtronic, LASAK s.r.o., Collagen Matrix, Inc., and OrthoPediatrics Corp. Companies are focused on developing advanced products to strengthen their market position.
No comments:
Post a Comment